The weekly litigation news digest is live. Subscribe now

Novel Synthesis Of Salcaprozic Acid By Amide Formation - EP4284774

The patent EP4284774 was granted to Novo Nordisk on Mar 12, 2025. The application was filed on Jan 28, 2022 under application number EP22703590A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4284774

NOVO NORDISK
Application Number
EP22703590A
Filing Date
Jan 28, 2022
Status
Granted And Under Opposition
Feb 7, 2025
Publication Date
Mar 12, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ZHANGNov 28, 2025KAYAADMISSIBLE
JAMES POOLEOct 28, 2025CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONCN1446795
DESCRIPTIONUS5962710
DESCRIPTIONWO2008028859
INTERNATIONAL-SEARCH-REPORTCN111978193
OPPOSITIONCN111978193
OPPOSITIONUS5962710
OPPOSITIONWO2006063819

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents